Menu

Scripps Faculty Wants President Out

Some faculty members of the Scripps Research Institute are wary of a possible merger with USC and would like to oust the organization’s president.

Jul 7, 2014
Kerry Grens

WIKIMEDIA, ELIFE SCIENCES PUBLICATIONS, LTDThe University of Southern California (USC) in Los Angeles and the Scripps Research Institute (TSRI) in La Jolla are discussing some form of partnership, and Scripps faculty members are not happy about it. U-T San Diego reported on Friday (July 4) that professors there have begun “an unprecedented faculty revolt” to oust Scripps’s president, Michael Marletta.

Last week, all of the institute’s department chairs and its dean sent a letter to the chair of the board of trustees expressing their lack of confidence in Marletta. At issue is a possible merger with or takeover by USC, which faculty members said they want dropped. Additionally, members have said that Marletta has not done enough to buoy Scripps’s sinking financial situation.

Marletta told U-T San Diego, “there are more than 250 faculty members at Scripps. It is impractical to involve every single one of them in a time-consuming and exhaustive review of options for the institute’s future.”

A partnership with USC may help the financially troubled TSRI, which is projecting a $21 million operating deficit this year. Peter Farrell, a Scripps trustee, said, “I can tell you categorically that what USC would like is for TSRI to not only keep what it's been doing, but to do it better. USC is in a position when it can provide plenty of resources.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!